COMMUNICATIONS ET AUTRES ARTICLES

Lors de cette période de thèse, j’ai été amené à présenter mes résultats de thèse dans différents congrès et réunions médicales et/ou scientifiques sous forme soit de présentation orale soit affichée dont le détail est développé ci-dessous :

- Congrès du cancéropôle Grand-Est 2013, Novembre 2013, Strasbourg

Communication orale : Le suppresseur de tumeur CDX2 augmente la chimiorésistance des cellules cancéreuses coliques au 5-Fluorouracile via le transporteur ABCC11

- JFHOD 2014, 32ème _{réunion du CECED, 20-21 mars 2014, Paris}

Communication orale : Le suppresseur de tumeur CDX2 augmente la chimiorésistance des cellules cancéreuses coliques au 5-Fluorouracile via le transporteur ABCC11

- Congrès AFC 2014, 1-3 octobre 2014, Paris

Communication orale : Le suppresseur de tumeur CDX2 augmente la chimiorésistance des cellules cancéreuses coliques au 5-Fluorouracile via le transporteur ABCC11

- 5èmes _{Journées de la FMTS, 27-28 avril 2017, Strasbourg}

Communication orale : Le suppresseur de tumeur CDX2 augmente la chimiorésistance des cellules cancéreuses coliques au 5-fluorouracile via le transporteur ABCC11.

Prix de la meilleure communication orale

- 4th _{Workshop on Basic Science on Peritoneal Carcinomatosis, Paris, juin 2017}

of colon cancer cells through the ABCC11 transporter

- 11th _{International Workshop on Peritoneal Surface Malignancy, Paris, 9-11}

septembre 2018

Communication affichée : The tumor suppressor gene CDX2 increases 5-Fluorouracile resistance of colon cancer cells through the ABCC11 transporter

Articles associés à la recherche clinique

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendicular and extra-appendicular origin. Delhorme JB,

Severac F, Averous G, Glehen O, Passot G, Bakrin N, Marchal F, Pocard M, Lo Dico R, Eveno C, Carrere S, Sgarbura O, Quenet F, Ferron G, Goéré D, Brigand C; French National Network of Peritoneal Surface Malignancies (RENAPE). Br J Surg (2018).

Surgery is an efficient option after failure of chemoradiation in anal canal and anal margin cancers. JB. Delhorme, F. Severac, W. Waissi, D. Antoni, KC. Freel, C. Schumacher,

S. Rohr, C. Brigand, G. Noel. Oncology (2017)

Management of rectal squamous cell carcinoma. Delhorme JB, Waissi W, Romain B,

Schumacher C, Freel KC, Dufour P, Brigand C, Rohr S. Clin Res Hepatol Gastroenterol (2017)

Prognostic factors of hemorrhagic complications after oxaliplatin-based HIPEC: toward routine preoperative dosage of Von Willebrand factor? JB. Delhorme, L. Sattler, E. Triki,

F. Severac, B. Romain, S. Rohr, L. Grunebaum, C. Brigand. Eur J Surg Oncol (2017)

Renal Angiomyolipomas: at Least Two Diseases. A Series of Patients Treated at Two European Institutions. J.B Delhorme, A. Fontana, A. Levy, P. Terrier, M. Fiore, D.Tzanis, A.

Gronchi, S. Bonvalot. Eur J Surg Oncol (2016)

Long-term survival after aggressive treatment of relapsed serosal or distant pseudomyxoma peritonei. Delhorme JB, Honoré C, Benhaim L, Dumont F, Dartigues P,

Dromain C, Ducreux M, Elias D, Goéré. Eur J Surg Oncol (2017)

Treatment that follows guidelines closely dramatically improves overall survival of patients with anal canal and margin cancers. JB. Delhorme, D. Antoni, KS. Mak, F. Severac,

KC. Freel, C. Schumacher, S. Rohr, C. Brigand, G. Noe.l Crit Rev Oncol Hematol (2016)

Can a benefit be expected from surgical debulking of unresectable Pseudomyxoma Peritonei ? JB. Delhorme, D. Elias, S. Varatharajah, L. Benhaim, F. Dumont, C. Honoré, D.

Peritoneal carcinomatosis with synchronous liver metastases from colorectal cancer: who will benefit from complete cytoreductive surgery? JB. Delhorme, L. Dupont-Kazma, P.

Addeo, F. Lefebvre, E. Triki, B. Romain, N. Meyer, P. Bachellier, S. Rohr, C. Brigand. Int J

Surg. (2015)

Preoperative detection of intrahepatic venovenous shunt treated by microwave precoagulation during right hepatectomy. JB. Delhorme, R. Méméo, J. Marescaux, P.

Pessaux. World J Gastrointest Pharmacol Ther (2015)

Routine second-look after surgical treatment of colonic peritoneal carcinomatosis. JB.

Delhorme, E. Triki, B. Romain, N. Meyer, S. Rohr, C. Brigand Journal of visceral surgery (2015)

Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chamotherapy (HIPEC) : The RENAPE Study. Malgras B, Gayat E, Aoun

O, Lo Dico R, Eveno C, Pautrat K, Delhorme JB, Passot G, Marchal F, Sgarbura O, Ferron G, Andre T, Pocard M ; RENAPE Network. Ann Surg Oncol. (2018)

Influence of preoperative life satisfaction on recovery and outcomes after colorectal cancer surgery - a prospective pilot study. Romain B, Rohmer O, Schimchowitsch S, Hübner

M, Delhorme JB, Brigand C, Rohr S, Guenot D. Health Qual Life Outcomes. (2018)

Proposal of a new preliminary scoring tool for early identification of significant blunt bowel and mesenteric injuries in patients at risk after road traffic crashes.

Raharimanantsoa M, Zingg T, Thiery A, Brigand C, Delhorme JB, Romain B. Eur J Trauma

Emerg Surg. (2017)

Could a Feeding Jejunostomy be Integrated into a Standardized Preoperative Management of Oeso-gastric Junction Adenocarcinoma? Manfredelli S, Delhorme JB,

Venkatasamy A, Gaiddon C, Brigand C, Rohr S, Romain B. Ann Surg Oncol. (2017)

Patterns of care and clinical outcomes in primary oesophageal gastrointestinal stromal tumours (GIST): A retrospective study of the French Sarcoma Group (FSG). Duffaud F,

Meeus P, Bertucci F, Delhorme JB, Stoeckle E, Isambert N, Bompas E, Gagniere J, Bouché O, Toulmonde M, Salas S, Blay JY, Bonvalot S; French Sarcoma Group. Eur J Surg Oncol. (2017)

Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery? Honoré

C, Atallah V, Mir O, Orbach D, Ferron G, LePéchoux C, Delhorme JB, Philippe-Chomette P, Sarnacki S, Msika S, Terrier P, Glehen O, Martelli H, Minard-Colin V, Bertucci F, Blay JY, Bonvalot S, Elias D, LeCesne A, Sargos P; French Network for Rare Peritoneal Malignancies (RENAPE), French Pediatric Cancer Society (SFCE), French Reference Network in Sarcoma Pathology (RRePS) French Sarcoma Clinical Network (NETSARC). PlosOne (2017)

Outcomes of hypnosis combined with local anesthesia during inguinal repair: a pilot study. Romain B, Rodriguez M, Story F, Delhorme JB, Brigand C, Rohr S. Hernia (2016)

Comparative study between biologic porcine dermal meshes: risk factors of postoperative morbidity and recurrence. Romain B, Story F, Meyer N, Delhorme JB, Brigand C, Rohr S. J

Wound Care (2016)

Prise en charge des fistules périanales dans la maladie de Crohn. Berdugo Y, Ngimpi-

Tambou M, Delhorme JB, Besch C, Brigand C, Rohr S, Duclos B, Reimund. JM Hepato Gastro (2016)

Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery. Benhaim L, Honoré C, Goéré D, Delhorme JB,

Elias D. Eur J Surg Oncol. (2016)

Pseudozyma aphidis fungemia after abdominal surgery: First adult case. Herb A, Sabou

M, Delhorme JB, Pessaux P, Mutter D, Candolfi E, Letscher-Bru V. Med Mycol Case Rep. (2015)

A case-control study of pre-operative levels of serum neutrophil gelatinase-associated lipocalin and other potential inflammatory markers in colorectal cancer. Duvillard L,

Ortega-Deballon P, Bourredjem A, Scherrer ML, Mantion G, Delhorme JB, Deguelte-Lardière S, Petit JM, Bonithon-Kopp C; AGARIC study group. BMC Cancer (2014)